nolomirole has been researched along with Cardiac Failure in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akkan, D; Andersson, C; Gislason, GH; Hassager, C; Kjaergaard, J; Køber, L; Møller, JE; Torp-Pedersen, C; Weeke, P | 1 |
| Bongrani, S; Cargnioni, A; Ferrari, R; Gitti, GL; Pasini, E; Pastore, F; Razzetti, R | 1 |
| Clark, AL; Cleland, JG; Coletta, AP; Ingle, L; Velavan, P | 1 |
| Akkan, D; Bruun, NE; Carlsen, JE; Dacoronias, D; Dickstein, K; Haghfelt, T; Køber, L; McMurray, JJ; Ohlin, H; Torp-Pedersen, C | 1 |
2 trial(s) available for nolomirole and Cardiac Failure
| Article | Year |
|---|---|
The prognostic importance of a history of hypertension in patients with symptomatic heart failure is substantially worsened by a short mitral inflow deceleration time.
Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Chi-Square Distribution; Comorbidity; Double-Blind Method; Echocardiography, Doppler, Pulsed; Female; Heart Failure; Humans; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Mitral Valve; Multivariate Analysis; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Scandinavian and Nordic Countries; Stroke Volume; Tetrahydronaphthalenes; Time Factors; Ventricular Function, Left | 2012 |
A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure.
Topics: Aged; Double-Blind Method; Esters; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Prospective Studies; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Tetrahydronaphthalenes; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2008 |
2 other study(ies) available for nolomirole and Cardiac Failure
| Article | Year |
|---|---|
Effect of nolomirole on monocrotaline-induced heart failure.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Aldosterone; Animals; Ascitic Fluid; Atrial Natriuretic Factor; Body Weight; Disease Models, Animal; Dopamine Agonists; Drug Evaluation, Preclinical; Esters; Female; Heart Atria; Heart Failure; Heart Ventricles; Hypertrophy, Right Ventricular; Indoles; Monocrotaline; Norepinephrine; Pleural Effusion; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes | 2004 |
Clinical trials update from the European Society of Cardiology Heart Failure meeting and the American College of Cardiology: darbepoetin alfa study, ECHOS, and ASCOT-BPLA.
Topics: Clinical Trials as Topic; Darbepoetin alfa; Erythropoietin; Esters; Heart Failure; Humans; Tetrahydronaphthalenes | 2005 |